ArticleFrontiers in immunology2025
Role of DNA methylation in regulating inflammatory cytokine expression in neonates with late-onset sepsis.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neonatal sepsis is a major health issue, particularly in resource-poor areas. This study aimed to assess the role of DNA methylation in regulating the inflammatory cytokine expression in late-onset neonatal sepsis (LOS). Methodology: We conducted a cross-sectional study comparing neonates with LOS (n=42) before and after 72 hours of antibiotic treatment (n=25) to healthy controls (HC) (n=42). We analysed DNA methylation patterns and inflammatory cytokine expression levels in both groups. Results: DNA methylation analysis revealed hypomethylation in pro-inflammatory genes and hypermethylation in anti-inflammatory genes in LOS neonates. These patterns were shifted in follow-up group, with significant changes in inflammatory marker levels, including TNF-α, IFN-γ, IL-10, and TGF-β. The gene expression results aligned with the DNA methylation findings, indicating that changes in the expression of inflammatory genes in late-onset neonatal sepsis (LONS) are influenced by DNA methylation. The results were further validated through an analysis of plasma cytokine levels. LOS cases showed elevated pro-inflammatory cytokines and reduced anti-inflammatory cytokines, except IL-10. In the follow-up group, pro-inflammatory cytokine levels decreased, while anti-inflammatory cytokines increased. Conclusion: DNA methylation regulates the expression of inflammatory cytokine genes in late-onset neonatal sepsis. Understanding these molecular changes could lead to better diagnostic and therapeutic approaches for managing neonatal sepsis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.